Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cyagen logo — Using proven methods to bring your custom model idea to life...

Cyagen

Using proven methods to bring your custom model idea to life.

Founded 2005 United States Santa Clara, United States 113 employees Series B Total: $41.00M Biotechnology, Manufacturing +1

General Information

Company Name Cyagen
Founded Year 2005
Location United States Santa Clara, United States +2
Employees 113
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Series B
Social

Get notified when Cyagen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cyagen

Cyagen is a 900-employee company headquartered in Santa Clara, California, with additional locations in Germany, Japan, and China. The company's slogan, "Using proven methods to bring your custom model idea to life," encapsulates its mission to provide tailored solutions for biomedical scientists' gene research needs. As the world's largest provider of custom-engineered mouse and rat models, Cyagen offers comprehensive services ranging from DNA vector construction to breeding, characterized by flexibility, top quality, full guarantees, and competitive prices. Moreover, Cyagen provides Contract Research Organization (CRO) services for cell and gene therapy (CGT) research, covering viral vector development, CAR design and construction, disease models, phenotype analysis, and pharmacodynamic evaluations. The company also offers a wide range of stem cell products for research use, including cell lines, media, and differentiation kits. With an array of services that cater to the growing demands of the biomedical research sector, Cyagen presents a compelling opportunity for venture capital firms seeking to invest in the burgeoning field of genetic research and biotechnology. The company's multi-location presence, commitment to quality, and diverse product offerings position it as an attractive prospect for potential investors looking to tap into the rapidly expanding life sciences market.

Taxonomy: Biomedical research, Genetic engineering, Mouse models, Rat models, Gene therapy, Custom model generation, Stem cell products, Cell and gene therapy research, Contract Research Organization, Viral vector development, CAR design, Phenotype analysis, Pharmacodynamic evaluations, Biotechnology services, DNA vector construction

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor Investor
•••• •••• 		26 Feb 2020

Cyagen Alternatives & Competitors

Cyagen vs
Cognate BioServices
Cognate BioServices

Cognate BioServices is a contract development and manufacturing organization for cell and gene-media...

Cyagen vs
Genezen
Genezen United States

Bringing Therapies to Life

Growth
272 employees
Compare Cyagen vs Genezen
Cyagen vs
Takara Bio USA, Inc.
Takara Bio USA, Inc. United States

Empowering gene and cell therapy with comprehensive manufacturing and customer services.

296 employees
Biotechnology
Compare Cyagen vs Takara Bio USA, Inc.
Also compare with: Cyagen vs Eureka Biotechnology Co., Limited Eureka Biotechnology Co., Limited

FAQ About Cyagen

Using proven methods to bring your custom model idea to life.
Cyagen was founded in 2005.
Cyagen is headquartered in Santa Clara, United States.
Cyagen operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.
Cyagen has approximately 113 employees.
Cyagen has completed 1 funding round, raising a total of $41.00M. The latest funding stage is Series B.
Top alternatives and competitors to Cyagen include Cognate BioServices, Genezen, Takara Bio USA, Inc., Eureka Biotechnology Co., Limited, ProtaGene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyagen and Cognate BioServices are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cyagen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy